The Kansas Department of Health and Environment is seeking competitive proposals from qualified vendors to provide 2nd tier analysis of dried blood spots for Lysosomal Disorders via Next-generation Sequencing (NGS) for approximately 250 newborn screening specimens annually.
The services covered in this contract will include Next-generation Sequencing (NGS) of dried blood spot specimens for lysosomal disorders currently screened and considered for future screening in the KHEL Newborn Screening section. The vendor will provide a price per condition screened. Services include NGS analysis of IDUA gene (MPS I), IDS gene (MPS II), GAA gene (Pompe), GALC gene (Krabbe), ARSA gene (MLD), and DMD gene (DMD). All NGS results must be provided to KHEL on an official report generated by the vendor with vendor letterhead, and must be received by KHEL within fourteen (14) business days of vendor receipt of dried blood spot specimen.
We post new medical & laboratory opportunities in Kansas as agencies publish them. Get them in one email — free, and unsubscribe whenever.
Most Kansas work asks for the two below, and the solicitation documents are where it’s stated. Here’s what each costs through Light RFP if you need one.
Source: Kansas eSupplier (event EVT0010938), retrieved via the Kansas eSupplier public bid portal. View the official posting, and always confirm requirements and deadlines with the issuing agency.